CompanyGraph
At a glance
- Depends onMidstream position: 5 outgoing, 6 incoming connections
- ScaleRevenue is $1.79B, above the global median of $520.53M
- PositionDebt-to-equity is 0.14×, lower than 95% of its Pharmaceutical Retailers peers (median 0.7×)
- Interpretations2 currently firing — 2
Sign in to view price data.
Sign inWhat the company actually pays, and whether its own cash supports it.
Dividends view
Yield
2.63%Above 5Y avg (2.56%)
Annual Rate
JPY 100.00Paid annual
Payout Ratio
55.9%Sustainable
Next Ex-Dividend
Sep 14, 2026
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
67.56BJPY423.30M · vs all stocks (USD)
Trailing P/E
26.53xvs Pharmaceutical Retailers peers
Revenue (TTM)
285.45BJPY1.79B · vs all stocks (USD)
Profit Margin
1.14%vs Pharmaceutical Retailers peers
Beta
0.1680xvs all stocks
52-Week Change
35.09%vs all stocks
Market Capitalization
67.56BJPY423.30M · vs all stocks (USD)
Enterprise Value
57.87BJPY362.60M · vs all stocks (USD)
Trailing P/E
26.53xvs Pharmaceutical Retailers peers
Price to Sales (TTM)
0.2973xvs Pharmaceutical Retailers peers
Price to Book (MRQ)
0.7391xvs Pharmaceutical Retailers peers
Enterprise to Revenue
0.2030xvs Pharmaceutical Retailers peers
Enterprise to EBITDA
5.08xvs Pharmaceutical Retailers peers
Profit Margin
1.14%vs Pharmaceutical Retailers peers
Operating Margin
1.99%vs Pharmaceutical Retailers peers
Return on Assets (TTM)
2.13%vs Pharmaceutical Retailers peers
Return on Equity (TTM)
2.85%vs Pharmaceutical Retailers peers
Revenue (TTM)
285.45BJPY1.79B · vs all stocks (USD)
Revenue per Share (TTM)
12.78KJPYUpdated Aug 19, 2026Quarterly Revenue Growth
1.30%vs Pharmaceutical Retailers peers
Gross Profit (TTM)
65.52BJPY410.50M · vs all stocks (USD)
EBITDA (TTM)
12.55BJPY78.62M · vs all stocks (USD)
Net Income (TTM)
3.26BJPY20.41M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
5.50%vs Pharmaceutical Retailers peers
Operating Cash Flow (TTM)
8.87BJPY55.54M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
3.20BJPY20.05M · vs all stocks (USD)
Trailing Annual Dividend Rate
100.00JPYUpdated Aug 19, 2026Trailing Annual Dividend Yield
2.63%vs all stocks
5-Year Average Dividend Yield
2.56%vs all stocks
Payout Ratio
55.89%vs Pharmaceutical Retailers peers
Revenue
284.49BJPYFY2026 · Mar 31, 2026Cost of Goods Sold
219.17BJPYFY2026 · Mar 31, 2026Gross Profit
65.32BJPYFY2026 · Mar 31, 2026Operating Income
6.78BJPY42.48M · vs all stocks (USD)
Pre-tax Income
5.57BJPYFY2026 · Mar 31, 2026Income Tax Expense
2.37BJPYFY2026 · Mar 31, 2026Net Income
3.20BJPYFY2026 · Mar 31, 2026EBIT
5.64BJPYFY2026 · Mar 31, 2026EBITDA (Income Statement)
12.55BJPYFY2026 · Mar 31, 2026Non-operating Interest Income
23.00MJPYFY2026 · Mar 31, 2026Non-operating Interest Expense
70.00MJPYFY2026 · Mar 31, 2026Preferred Stock Dividends
0.00JPYFY2026 · Mar 31, 2026Operating Cash Flow
4.34BJPYFY2026 · Mar 31, 2026Free Cash Flow
147.00MJPYFY2026 · Mar 31, 2026Cash & Cash Equivalents (End of Period)
38.11BJPYFY2026 · Mar 31, 2026Starting Profit (CF Statement)
5.57BJPYFY2026 · Mar 31, 2026Other Non-cash Items
41.00MJPYFY2026 · Mar 31, 2026Change in Accounts Receivable (CF)
-1.11BJPYFY2026 · Mar 31, 2026Change in Other Assets/Liabilities
-164.00MJPYFY2026 · Mar 31, 2026Capital Expenditures
-4.20BJPYFY2026 · Mar 31, 2026Net Intangibles (CF)
-114.00MJPYFY2026 · Mar 31, 2026Other Investing Activity
-846.00MJPYFY2026 · Mar 31, 2026Net Investing Cash Flow
-5.04BJPYFY2026 · Mar 31, 2026Long-term Debt Issuance
5.90BJPYFY2026 · Mar 31, 2026Long-term Debt Payments
-6.38BJPYFY2026 · Mar 31, 2026Common Dividends Paid
-1.78BJPYFY2026 · Mar 31, 2026Other Financing Charges
-1.00MJPYFY2026 · Mar 31, 2026Net Financing Cash Flow
-2.27BJPYFY2026 · Mar 31, 2026Shares Outstanding
22.33MSharesUpdated Aug 19, 2026Float Shares
12.63MSharesUpdated Aug 19, 2026% Held by Insiders
39.69%vs all stocks
% Held by Institutions
16.60%vs all stocks
Total Cash (MRQ)
44.63BJPY279.62M · vs all stocks (USD)
Total Cash per Share (MRQ)
2.00KJPYUpdated Aug 19, 2026Total Debt (MRQ)
16.51BJPY103.46M · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.1438xvs Pharmaceutical Retailers peers
Current Ratio (MRQ)
1.51xvs Pharmaceutical Retailers peers
Book Value per Share (MRQ)
5.14KJPYUpdated Aug 19, 2026Total Assets
199.61BJPY1.25B · vs all stocks (USD)
Total Current Assets
93.32BJPYFY2026 · Mar 31, 2026Total Liabilities
83.69BJPYFY2026 · Mar 31, 2026Total Non-current Assets
106.29BJPYFY2026 · Mar 31, 2026Total Non-current Liabilities
23.28BJPYFY2026 · Mar 31, 2026Total Current Liabilities
60.41BJPYFY2026 · Mar 31, 2026Cash & Cash Equivalents
38.11BJPYFY2026 · Mar 31, 2026Accounts Receivable
15.83BJPYFY2026 · Mar 31, 2026Inventory
34.58BJPYFY2026 · Mar 31, 2026Accounts Payable
41.87BJPYFY2026 · Mar 31, 2026Short-term Debt
5.71BJPYFY2026 · Mar 31, 2026Other Current Liabilities
7.60BJPYFY2026 · Mar 31, 2026Long-term Debt
10.41BJPYFY2026 · Mar 31, 2026Other Non-current Liabilities
879.00MJPYFY2026 · Mar 31, 2026Common Stock (Book)
13.00BJPYFY2026 · Mar 31, 2026Retained Earnings
92.18BJPYFY2026 · Mar 31, 2026Total Shareholders' Equity
115.92BJPY726.33M · vs all stocks (USD)
Treasury Stock
4.36BJPYFY2026 · Mar 31, 202652-Week Low
2.79KJPYUpdated Aug 19, 202652-Week High
3.90KJPYUpdated Aug 19, 202652-Week Change
35.09%vs all stocks
Beta
0.1680xvs all stocks
50-Day MA
3.47KJPYUpdated Aug 19, 2026200-Day MA
3.15KJPYUpdated Aug 19, 2026Avg 10-Day Volume
97.45KSharesUpdated Aug 19, 2026Avg 30-Day Volume
69.95KSharesUpdated Aug 19, 2026Diluted EPS (TTM)
143.22JPYUpdated Aug 19, 20262 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsIs this company financially stable?
Low-Leverage Liquidity Configuration
Cash on hand covers most or all of its debt, and its equity share of assets is high for its industry.
Reads
How is this stock valued?
High Retained Earnings With Profitability And Equity
Profits kept in the business fund much of what it owns, after five straight profitable years.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Peer Positioning
Debt-to-equity is 0.14×, lower than 95% of its Pharmaceutical Retailers peers (median 0.7×)Notable
Debt-to-equity: 0.14Industry median: 0.70Industry P5: 0.19Peers compared: 22.00
Price-to-book is 0.74×, lower than 95% of its Pharmaceutical Retailers peers (median 1.84×)Notable
Price-to-book: 0.74Industry median: 1.84Industry P5: 0.75Peers compared: 22.00
Financial Health
Altman Z-Score 2.85: safe zoneNotable
Altman Z-Score: 2.85
High earnings qualityNotable
Earnings Quality Score: 0.72
Supply Chain
Midstream position: 5 outgoing, 6 incoming connectionsNotable
Outgoing: 5.00Incoming: 6.00
High connectivity hub: 11 industry connectionsNotable
Total Connections: 11.00
Scale
Revenue is $1.79B, above the global median of $520.53MNotable
Revenue (USD): 1,788,474,517.783Global Median: 520,528,949.311
Levered free cash flow is $20.05M, above the global median of $16.24MNotable
Levered free cash flow (USD): 20,049,600Global Median: 16,239,329.704
Companies that share the same coordination system — how they create, deliver, or capture value.
Erajaya Swasembada Tbk.
Tier 1FlowUnit ReplicationInterfaceRisk
Kosaido Holdings Co., Ltd.
Tier 1FlowUnit ReplicationInterfaceProduction
Haverty Furniture Companies Inc.
Tier 1FlowUnit ReplicationInterfaceAttention
Genesco Inc.
Tier 1FlowUnit ReplicationRiskInterface
Barnes & Noble Education Inc.
Tier 1FlowUnit ReplicationInterfaceProduction
Guoanda Co., Ltd.
Tier 1FlowUnit ReplicationRule
Padini Holdings Berhad
Tier 1FlowUnit ReplicationRiskInterface
Yasuda Logistics Corporation
Tier 1FlowUnit ReplicationProductionInterface
Zedcor Inc.
Tier 1FlowUnit ReplicationRuleRisk
Franchise Brands plc
Tier 1FlowUnit ReplicationProductionInterface
Companies that share active interpretations — structural patterns currently present in both stocks.
Jiangsu Hengli Hydraulic Co., Ltd.
2 interpretationsLow-Leverage Liquidity ConfigurationHigh Retained Earnings With Profitability And Equity
Shanghai Geoharbour Construction Group Co. Ltd.
2 interpretationsLow-Leverage Liquidity ConfigurationHigh Retained Earnings With Profitability And Equity
Wuxi Honghui New Materials Co., Ltd.
2 interpretationsLow-Leverage Liquidity ConfigurationHigh Retained Earnings With Profitability And Equity